Osteoporosis is an "insidious" condition characterized by the progressive and silent reduction of skeletal bone mass and the loss of bone strength, making bones more fragile. It directly threatens the quality of life - primarily in postmenopausal women due to the sharp decline in estrogen levels, though it also affects men to a significant degree. The primary hallmark of the disease is that it is asymptomatic, especially in its early stages, frequently remaining undiagnosed until a major event occurs, such as a low-impact osteoporotic fracture, usually following a simple fall or slip.
In modern medicine, screening is considered essential, as fractures - particularly of the spine and hip - have adverse consequences, cause disabilities, and are associated with increased mortality. External factors play a vital role in prevention and skeletal fortification, including proper nutrition with adequate calcium and phosphorus intake, vitamin D synthesis through sun exposure and dietary sources, systematic exercise, and the limitation of factors such as smoking and excessive consumption of alcohol and coffee.
Early diagnosis and proper awareness are the primary foundational steps, as the risk of developing the disease is influenced by heredity, early menopause, the use of specific medications (such as corticosteroids), or the presence of chronic underlying conditions. The evaluation of these risk factors determines when specialized clinical screening and the initiation of appropriate preventive or therapeutic management are imperative.
Diagnostic Evaluation
Clinical assessment includes fundamental and reliable diagnostic methods:
- Bone Mineral Density (BMD) Testing (DEXA): A simple, quick, and painless examination recommended for the spine and hip. Results are compared with healthy young adults to diagnose osteopenia or osteoporosis.
- Biochemical Bone Profile: Blood tests to evaluate calcium, phosphorus, parathyroid hormone (PTH), vitamin D, and alkaline phosphatase.
- Radiological Examination: Essential, particularly in cases with a history of spinal pain, to detect potential fractures.
- FRAX Special Diagnostic Protocols: Applied under specific criteria to predict the 10-year fracture risk.
Management and Therapeutic Approach
The primary therapeutic goal is to reduce fracture risk. Treatment selection is based on bone mass values and a comprehensive assessment of risk factors, in accordance with official guidelines from the World Health Organization (WHO) and the Hellenic Osteoporosis Foundation (ELIOS). Available anti-osteoporotic medications are divided into antiresorptives (which inhibit bone tissue resorption) and osteoanabolic agents (which promote new bone formation), while therapy is always accompanied by the administration of appropriate doses of calcium and vitamin D.
The Osteoporosis Clinic
The Osteoporosis Clinic at Metropolitan Hospital is staffed by specialized physicians and provides comprehensive clinical evaluation, preventive screening, and personalized management of the disease. Guided by contemporary medical guidelines, the Clinic's objective is the early recognition of fracture risk, the design of appropriate therapeutic regimens, and the long-term protection of skeletal health, ensuring the best possible quality of life for every patient.
Head of the Osteoporosis Clinic: Ioannis Nikolopoulos, MD, MSc, Orthopedic Surgeon